Q3 FY2026 · ended Sep 26, 2026 · Revenue $7.86B, +2.2% YoY · Filed Nov 4, 2026
Medline Inc. (MDLN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 26, 2026, it reported revenue of $7.9 billion and net income of $318.0 million. Free cash flow was $884.0 million. As of Sep 26, 2026 it held $3.6 billion in cash and investments and $12.6 billion in total debt.
Revenue
$7.86B
+2.2% vs prior quarter
Net income
$318.00M
+128.8% vs prior quarter
Operating cash flow
$1.02B
+43.4% vs prior quarter
Free cash flow
$884.00M
+46.4% vs prior quarter
EPS
$0.22
+214.3% vs prior quarter
Dividend per share
None
Shares outstanding
—
Net cash
$-9.04B
Q3 FY2026
Operating margin
6.4%
Q3 FY2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MDLN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northfield, IL
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 2046386
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 26, 2026 |
Q2 FY2026 Jun 27, 2026 |
Q1 FY2026 Mar 28, 2026 |
|---|---|---|---|
| Revenue | $7.9B | $7.7B | $7.4B |
| Operating income | $500.0M | $395.0M | $422.0M |
| Net income | $318.0M | $139.0M | $239.0M |
| Diluted EPS | $0.22 | $0.07 | $0.16 |
| Operating cash flow | $1.0B | $715.0M | $412.0M |
| Free cash flow | $884.0M | $604.0M | $316.0M |
| Total assets | $40.2B | $39.4B | $39.0B |
| Total liabilities | $20.8B | $20.3B | $19.7B |
| Stockholders' equity | $11.8B | $11.6B | $11.3B |
| Cash and investments | $3.6B | $2.7B | $2.2B |
| Total debt | $12.6B | $12.6B | $12.6B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 26, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 13, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 27, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 158 Medline Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.